ArticleAnalytical and bioanalytical chemistry2026
Accounting for methodological variabilities in disease outbreak surveillance using wastewater-based epidemiology: a case study with SARS-CoV-2.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Wastewater-based surveillance of SARS-CoV-2 has become an established approach for monitoring health status and disease outbreak at the community level. Although analytical protocols for RNA quantification have been widely implemented and optimised, the characterisation of variability introduced across all stages, such as storage, sample processing, and PCR quantification, remained limited, including its impact upon epidemiological interpretation. This study proposes an analytical framework to quantify variability across the complete workflow for SARS-CoV-2 RNA measurement in wastewater, including storage stability, sample processing, and PCR quantification. This framework was developed for a large SARS-CoV-2 dataset of two viral gene targets (N1, E-Sarbeco), which were quantified alongside human-associated CrAssphage for a total of 20,124 RT-qPCR data points derived from four water recycling centres (WRCs) over a 24-month period. This analysis revealed that sample refrigeration yielded richer epidemiological data than freezing, and that CrAssphage had minimal utility as a normalisation biomarker given its higher variability. Quantification of analytical variability for SARS-CoV-2 targets enabled development of a composite metric (Total Estimated SARS-CoV-2), improving sensitivity and reducing non-detects at the expense of reduced precision. This novel multi-stage framework had the capability to improve the sensitivity and interpretation of WBE data and the characterisation of WBE methodologies, with broad applicability for pathogen monitoring.
Indexed as
Identifiers
42570023What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.